Phase II

Clinilabs specializes in executing Proof of Concept studies, offering clients scientific, operational, and regulatory expertise needed to move drug candidates into Phase III.
 
The successful completion of Phase II studies requires the enrollment of targeted patient populations at small numbers of investigator sites.  Data quality and integrity are critical in this phase of drug development in order to identify successful late stage strategies and avoid costly clinical development failures.
 
Clinilabs provides clients with access to investigator sites that are certified to collect and transfer data to the Company’s core data center.  We have hundreds of investigators in our database that have Phase II experience, and that provide access to key patient populations. These high-caliber sites link to our electronic technologies in order to execute studies in a timely and cost-efficient manner.